View in EDS HTML Full Text PDF Full Text

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.

Saved in:
Bibliographic Details
Title: Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.
Authors: Huang, Si‐Man1,2,3 (AUTHOR), Wan, Chao‐Ling1,2,3 (AUTHOR), Cao, Han‐Yu1,2,3 (AUTHOR), Li, Yan‐Yan1,2,3 (AUTHOR), Qian, Chong‐Sheng1,2,3 (AUTHOR), Zhou, Hai‐Xia1,2,3 (AUTHOR), Xu, Ming‐Zhu1,2,3 (AUTHOR), Hu, Xiao‐Hui1,2,3 (AUTHOR), Dai, Lan1,2,3 (AUTHOR), Dai, Hai‐Ping1,2,3 (AUTHOR) daihaiping8@126.com, Xue, Sheng‐Li1,2,3 (AUTHOR) slxue@suda.edu.cn
Source: Clinical Case Reports. Dec2023, Vol. 11 Issue 12, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 174634970
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Huang%2C+Si‐Man%22">Huang, Si‐Man</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Chao‐Ling%22">Wan, Chao‐Ling</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Han‐Yu%22">Cao, Han‐Yu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yan‐Yan%22">Li, Yan‐Yan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qian%2C+Chong‐Sheng%22">Qian, Chong‐Sheng</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Hai‐Xia%22">Zhou, Hai‐Xia</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Ming‐Zhu%22">Xu, Ming‐Zhu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Xiao‐Hui%22">Hu, Xiao‐Hui</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dai%2C+Lan%22">Dai, Lan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dai%2C+Hai‐Ping%22">Dai, Hai‐Ping</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> daihaiping8@126.com</i><br /><searchLink fieldCode="AR" term="%22Xue%2C+Sheng‐Li%22">Xue, Sheng‐Li</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> slxue@suda.edu.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+Case+Reports%22">Clinical Case Reports</searchLink>. Dec2023, Vol. 11 Issue 12, p1-5. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174634970
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ccr3.8289
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 1
    Titles:
      – TitleFull: Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang, Si‐Man
      – PersonEntity:
          Name:
            NameFull: Wan, Chao‐Ling
      – PersonEntity:
          Name:
            NameFull: Cao, Han‐Yu
      – PersonEntity:
          Name:
            NameFull: Li, Yan‐Yan
      – PersonEntity:
          Name:
            NameFull: Qian, Chong‐Sheng
      – PersonEntity:
          Name:
            NameFull: Zhou, Hai‐Xia
      – PersonEntity:
          Name:
            NameFull: Xu, Ming‐Zhu
      – PersonEntity:
          Name:
            NameFull: Hu, Xiao‐Hui
      – PersonEntity:
          Name:
            NameFull: Dai, Lan
      – PersonEntity:
          Name:
            NameFull: Dai, Hai‐Ping
      – PersonEntity:
          Name:
            NameFull: Xue, Sheng‐Li
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 20500904
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical Case Reports
              Type: main
ResultId 1